Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation.
Knockout of secretin receptor reduces large cholangiocyte hyperplasia in mice with extrahepatic cholestasis induced by bile duct ligation.
复制标题
DOI:
10.1002/hep.23657
复制
发表时间:
2010-07
期刊:
影响因子:
13.5
通讯作者:
Alpini, Gianfranco
中科院分区:
文献类型:
--
作者:
Glaser, Shannon;Lam, Ian P.;Franchitto, Antonio;Gaudio, Eugenio;Onori, Paolo;Chow, Billy K.;Wise, Candace;Kopriva, Shelley;Venter, Julie;White, Mellanie;Ueno, Yoshiyuki;Dostal, David;Carpino, Guido;Mancinelli, Romina;Butler, Wendy;Chiasson, Valorie;DeMorrow, Sharon;Francis, Heather;Alpini, Gianfranco
During bile duct ligation (BDL), the growth of large cholangiocytes is regulated by the cAMP/ERK1/2 pathway and is closely associated with increased secretin receptor (SR) expression. Although it has been suggested that the SR modulates cholangiocyte growth, direct evidence for secretin-dependent proliferation is lacking. SR+/+ (wild-type, WT) or SR knockout (SR−/−) mice underwent sham surgery or BDL for 3 or 7 days. We evaluated: (i) SR expression, cholangiocyte proliferation, and apoptosis in liver sections; and (ii) PCNA protein expression and ERK1/2 phosphorylation in purified large cholangiocytes from WT and SR−/− BDL mice. Normal WT mice were treated with secretin (2.5 nmoles/Kg BW/day by osmotic minipumps for 1 week) and biliary mass was evaluated. Small and large cholangiocytes were used to evaluate the in vitro effect of secretin (100 nM) on proliferation, PKA activity and ERK1/2 phosphorylation. SR expression was also stably knocked down by shRNA, and basal and secretin-stimulated cAMP levels (a functional index of biliary growth) and proliferation were determined. SR was expressed by large cholangiocytes. Knockout of SR significantly decreased large cholangiocyte growth induced by BDL, which was associated with enhanced apoptosis. PCNA expression and ERK1/2 phosphorylation were decreased in large cholangiocytes from SR−/− BDL compared to WT BDL mice. In vivo administration of secretin to normal WT mice increased ductal mass. In vitro, secretin increased proliferation, PKA activity and ERK1/2 phosphorylation of large cholangiocytes that was blocked by PKA and MEK inhibitors. Stable knockdown of SR expression reduced basal cholangiocyte proliferation. SR is an important trophic regulator sustaining biliary growth. The current study provides strong support for the potential use of secretin as a therapy for ductopenic liver diseases.
登录
查看更多内容
影响因子:
25.7
作者:
Korner, Meike;Hayes, Gregory M.;Reubi, Jean Claude
通讯作者:
Reubi, Jean Claude
DOI:
10.1038/labinvest.2009.6
发表时间:
2009-04
期刊:
Laboratory investigation; a journal of technical methods and pathology
影响因子:
--
作者:
通讯作者:
--
DOI:
10.1152/ajpgi.1999.276.5.g1289
发表时间:
1999-05-01
影响因子:
4.5
作者:
LeSage, GD;Glaser, SS;Alpini, G
通讯作者:
Alpini, G
影响因子:
29.4
作者:
Miyoshi, H;Rust, C;Gores, GJ
通讯作者:
Gores, GJ
影响因子:
29.4
作者:
Alpini, G;Roberts, S;LaRusso, NF
通讯作者:
LaRusso, NF